Literature DB >> 725497

Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23--27 years' follow-up examinations.

T Ihamäki, M Saukkonen, M Siurala.   

Abstract

261 subjects with a normal body mucosa or with superficial gastritis used as controls for an atrophic gastritis series have been followed up for 23--27 years. Of them, 41 died during the earlier and 63 during the present follow-up period. In all, 141 subjects were reexamined in 1976--1977 and 16 answered a questionnaire. None of the subjects had gastric carcinoma or an adenomatous polyp. One patient diagnosed and reported earlier had died of gastric carcinoma during the present period of observation. Of the subjects with normal body mucosa 58% had developed superficial and 14% atrophic gastritis. Of those with superficial body gastritis 42% had developed atrophic gastritis and 18% showed an improvement of the gastritic changes. It should be noted, however, that earlier examinations were performed with blind biopsy and the present with direct vision gastroscopic biopsy. The state of the antral and body mucosa was similar in 53%, antral changes dominated in 33% and the changes in the body in 14%. Intestinal metaplasia was found in 36%, atypical epithelium in 6%, parietal cell antibodies in 0.5% and intrinsic factor antibodies in 0.5%. The fasting serum gastrin level was above 100 ng/ml in 10%. Only 2 cases fulfilled the morphological, functional and immunological criteria of type A gastritis. The present controls differed from the atrophic gastritis series in that the topography of gastritis was different and in that the incidence of metaplasia, atypia, gastric antibodies and high serum gastrin levels was markedly lower.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 725497     DOI: 10.3109/00365527809182189

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

Review 1.  An approach to dyspepsia in the ambulatory care setting: evaluation based on risk stratification.

Authors:  S C Zell; M Budhraja
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

Review 2.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 3.  The dynamics of gastritis.

Authors:  E J Kuipers; T A Grool
Journal:  Curr Gastroenterol Rep       Date:  2001-12

4.  Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens.

Authors:  R Piccolomini; G Di Bonaventura; D Festi; G Catamo; F Laterza; M Neri
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

6.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

Review 7.  Assessing risks for gastric cancer: new tools for pathologists.

Authors:  Robert M Genta; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

8.  Gastroduodenal inflammation in patients with non-ulcer dyspepsia. A controlled endoscopic and morphometric study.

Authors:  A U Toukan; M F Kamal; S S Amr; M A Arnaout; A S Abu-Romiyeh
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

9.  Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.

Authors:  R J Schlemper; S D van der Werf; J P Vandenbroucke; I Biemond; C B Lamers
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

10.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.

Authors:  N Broutet; M Plebani; C Sakarovitch; P Sipponen; F Mégraud
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.